Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasm Metastasis 9Colorectal Neoplasms 7Rectal Neoplasms 5Colorectal Cancer Metastatic 5Ovarian Neoplasms 4Neoplasms 4Lung Neoplasms 3Colonic Neoplasms 3Uveal Melanoma 2Melanoma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Somatostatinoma 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neurofibromatosis 2 1Myeloproliferative Disorders 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Macular Degeneration 1

Interventions

fludarabine phosphate 18Peripheral Blood Stem Cell Transplantation 15Whole-Body Irradiation 14Mycophenolic Acid 14Cyclophosphamide 14Tacrolimus 10Cyclosporine 10Busulfan 10Antilymphocyte Serum 10Methotrexate 8Melphalan 7Etoposide 7Sirolimus 5Radiotherapy 5Filgrastim 5Cord Blood Stem Cell Transplantation 5Granulocyte Colony-Stimulating Factor 4Cytarabine 4Cyclosporins 4thymoglobulin 3Methylprednisolone 3Therapeutics 2Rituximab 2Ondansetron 2Flow Cytometry 2Dexamethasone 2Carmustine 2Carboplatin 2Calcium Dobesilate 2Aprepitant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × aflibercept × Clear all
NCT00509249 2015-01-08

Aflibercept in Treating Patients With Myelodysplastic Syndromes

National Cancer Institute (NCI)

Phase 2 Terminated
18 enrolled 4 charts
MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡